findmyKOL

Owais Khawaja, MD

Basic profile

Interventional Cardiology

ORCID↗NPI↗
✓ Full record
RegionUpper Sandusky, OH · MidwestSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL type: RegionalLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Owais Khawaja is a Cardiology physician. OpenAlex indexes 39 publications with 865 citations (h-index 18).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
39publications

Distinct works indexed by OpenAlex, matched via ORCID.

865citations

Total citations across indexed works.

18h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
18companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

885 N Sandusky Ave
Upper Sandusky, OH 433511098

Telephone

419-294-4991

Provider last certified this registry record 1 Feb 2023.

View the NPPES registry record

Industry payments

18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    83.1%
    Beta blocker22.3%
    Metoprolol Succinate53%Carvedilol35%Metoprolol Tartrate5%Sotalol4%Nebivolol Hcl3%
    Part D<11 patients
    Statin18.9%
    Atorvastatin Calcium74%Rosuvastatin Calcium17%Simvastatin6%Pravastatin Sodium3%
    Part D<11 patients

    + 16 more classes in this area

  • Blood & clotting

    11.8%
    P2Y12 inhibitor6.5%
    Clopidogrel89%Brilinta11%
    Part D<11 patients
    Factor Xa inhibitor5%
    Eliquis66%Xarelto35%
    Part D≥26 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    5.1%
    SGLT2 inhibitor3.7%
    Farxiga90%Jardiance10%
    Part D<11 patients
    Potassium supplement1.3%
    Potassium Chloride100%
    Part D≥12 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”